4th Annual Process Development for Cell Therapies Summit
The cell therapy landscape is rapidly evolving, driven by technological advancements, a surge in late-stage programs, and increasing cost pressures. As therapies become more complex and regulatory demands rise, there is an urgent need for refined process development strategies to accelerate the delivery of consistent, cost-effective therapies to patients.
The 4th Process Development for Cell Therapies Summit showcased 24+ industry leaders from biopharma and service providers as they shared best practices for driving process robustness, scalability, speed, and affordability. Attendees gained insights into how to develop consistent, scalable, and cost-effective solutions for both autologous and allogeneic cell therapies.